‘A slippery slope’: A looming nationwide abortion pill ban could undermine the entire drug approval system
Soon after the Supreme Court overturned Roe v. Wade, a former Republican congressman made what might sound like an unusual offer. Did abortion pill makers want him to try to get federal legislation passed to explicitly stop states from restricting medications that have been approved by the Food and Drug Administration?
His concern was about more than abortion pills themselves. After his stint in Congress, Jim Greenwood had spent 15 years as the president and CEO of one of the biopharma industry’s main lobbying groups. He figured that the 20-year-old approval of mifepristone might be in jeopardy. If an attempted ban prevailed in court, he knew, it could undermine the country’s infrastructure for evaluating all drugs. “Could states ban vaccines of one kind or another? It’s a slippery slope,” he said, adding, “There are lots of anti-vaxxers in lots of state legislatures.”
Information Courtesy By: Eric Boodman, #HealthcareNews #Healthcare | Feeds
Soon after the Supreme Court overturned Roe v. Wade, a former Republican congressman made what might sound like an unusual offer. Did abortion pill makers want him to try to get federal legislation passed to explicitly stop states from restricting medications that have been approved by the Food and Drug Administration?
His concern was about more than abortion pills themselves. After his stint in Congress, Jim Greenwood had spent 15 years as the president and CEO of one of the biopharma industry’s main lobbying groups. He figured that the 20-year-old approval of mifepristone might be in jeopardy. If an attempted ban prevailed in court, he knew, it could undermine the country’s infrastructure for evaluating all drugs. “Could states ban vaccines of one kind or another? It’s a slippery slope,” he said, adding, “There are lots of anti-vaxxers in lots of state legislatures.”
Click For More Details
2023-02-23 15:05
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.